• 1. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 2. An ionic liquid-mesoporous silica blend as a novel adsorbent for the adsorption and recovery of palladium ions, and its applications in continuous flow study and as an industrial catalyst?
  Shivani Sharma,Chia-Ming Wu,Ranjit T. Koodali,N. Rajesh RSC Adv., 2016,6, 26668-26678
• 3. Aggregation-induced emission of luminol: a novel strategy for fluorescence ratiometric detection of ALP and As(v) with high sensitivity and selectivity?
  Yuan-Jun Tong,Lu-Dan Yu,Lu-Lu Wu,Shu-Ping Cao,Ru-Ping Liang,Li Zhang,Xing-Hua Xia,Jian-Ding Qiu Chem. Commun., 2018,54, 7487-7490
• 4. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 5. An autoreduction method to prepare plasmonic gold-embedded polypeptide micelles for synergistic chemo-photothermal therapy?
  Xingjie Wu,Linzhu Zhou,Yue Su,Chang-Ming Dong J. Mater. Chem. B, 2016,4, 2142-2152

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Quinoline carboxylic acids

Professional Introduction to 8-Chloro-2-(thiophen-2-yl)quinoline-4-carboxylic Acid (CAS No. 52413-56-6)

8-Chloro-2-(thiophen-2-yl)quinoline-4-carboxylic acid, identified by its CAS number 52413-56-6, is a significant compound in the field of pharmaceutical chemistry. This heterocyclic molecule combines a quinoline core with a thiophene substituent, making it a versatile scaffold for drug discovery and development. The presence of a chloro group at the 8-position and a carboxylic acid moiety at the 4-position enhances its reactivity and potential applications in medicinal chemistry.

The compound's structure imparts unique electronic and steric properties, which are highly valuable in designing molecules with specific biological activities. Quinoline derivatives have long been recognized for their pharmacological significance, particularly in the treatment of infectious diseases and cancer. The integration of a thiophene ring introduces additional functionality, enabling further chemical modifications and tailoring of the molecule's properties.

In recent years, there has been a growing interest in quinoline-thiophene hybrids due to their demonstrated efficacy in various therapeutic areas. For instance, studies have shown that such compounds exhibit potent antimicrobial and anticancer properties. The structural features of 8-Chloro-2-(thiophen-2-yl)quinoline-4-carboxylic acid make it an attractive candidate for further investigation in these fields.

One of the most compelling aspects of this compound is its potential as a precursor for more complex drug molecules. The carboxylic acid group, in particular, provides a handle for further functionalization via esterification, amidation, or coupling reactions. These modifications can be strategically employed to enhance solubility, bioavailability, and target specificity. Moreover, the chloro substituent can participate in various chemical transformations, such as cross-coupling reactions, allowing for the introduction of diverse structural motifs.

The synthesis of 8-Chloro-2-(thiophen-2-yl)quinoline-4-carboxylic acid involves multi-step organic reactions that require careful optimization to achieve high yields and purity. Common synthetic routes include cyclization reactions followed by functional group interconversions. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making this compound more accessible for research and industrial applications.

Recent research has highlighted the importance of quinoline-thiophene hybrids in addressing emerging therapeutic challenges. For example, studies have demonstrated their potential in developing novel agents against drug-resistant pathogens. The ability to modulate the electronic properties of these molecules through structural variations has opened up new avenues for drug design. Additionally, computational studies have been instrumental in predicting the biological activity of 8-Chloro-2-(thiophen-2-yl)quinoline-4-carboxylic acid and its derivatives.

The compound's pharmacokinetic profile is another area of interest. By understanding how it is metabolized and eliminated from the body, researchers can design analogs with improved pharmacological properties. Preclinical studies have begun to explore its potential as an active pharmaceutical ingredient (API) in various formulations. These studies aim to establish dosing regimens and assess safety profiles before moving into human clinical trials.

In conclusion, 8-Chloro-2-(thiophen-2-yl)quinoline-4-carboxylic acid (CAS No. 52413-56-6) represents a promising scaffold for pharmaceutical innovation. Its unique structural features and reactivity make it a valuable tool for drug discovery efforts targeting infectious diseases and cancer. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in the development of next-generation therapeutics.

• 851546-83-3(2-Thiophen-2-yl-quinoline-4-carboxylic acid)
• 31792-49-1(6-Methyl-2-(thiophen-2-yl)quinoline-4-carboxylic acid)
• 33289-45-1(8-Methyl-2-(thiophen-2-yl)quinoline-4-carboxylic acid)
• 33289-51-9(6-Chloro-2-(thiophen-2-yl)quinoline-4-carboxylic acid)
• 73775-26-5(2-(5-Methylthien-2-yl)quinoline-4-carboxylic acid)
• 329222-93-7(2-(5-Chloro-thiophen-2-yl)-quinoline-4-carboxylic acid)
• 31792-47-9(2-(thiophen-2-yl)quinoline-4-carboxylic acid)
• 4599-09-1(2-(2,2'-bithiophen-5-yl)quinoline-4-carboxylic acid)
• 667412-63-7(8-Methyl-2-(5-methylthien-2-yl)quinoline-4-carboxylic Acid)
• 438216-88-7(6-Methyl-2-(5-methyl-2-thienyl)quinoline-4-carboxylic Acid)